Back to Agenda
Session 2: Patient Centric Labeling for Shared Decision-making in Healthcare
Session Chair(s)
Rie Matsui, RPH
Senior Director, Regional Labeling Head for APAC, Pfizer R&D Japan G.K., Japan
Brandon Stempo, MS
Practice Leader - Regulatory Strategy, CMC and Labeling, Opus Regulatory, United States
Nowadays patients often search for product information online, where they may encounter inaccurate and outdated information, since the sources are not always reliable. To empower patients to be active participants in their healthcare plan and enable shared decisions with their healthcare providers, it is essential to develop patient-centric labeling that prioritizes health literacy. This session will explore the patient needs for product information and discuss the best practices for developing patient-centric labeling that incorporates health literacy principles. In addition, this session will also highlight the importance for leveraging digital labeling initiatives to enhance patient access to reliable information in a patient friendly method.
Learning Objective : - Discuss the components and best practices for incorporating health literacy testing into labeling
- Describe the strategies for effective utilization of digital patient labeling
- Identify the current challenges in ensuring patients receive accurate and accessible information through active patient participation and digital initiatives
Speaker(s)
Karel Martinus van der Waarde, PHD, MA
Lecturer, Lucerne University of Applied Sciences and Arts, Switzerland
Labeling People Does Not Help Medicine Labeling
Marva Schodel, MBA, MS
Senior Director of Regulatory Affairs, Global Labeling Therapeutic Area Lead, an, Merck & Co., United States
Patient-Centric Labeling: Empowering Shared Decision-Making in Healthcare
Yuri Quintana, PHD
Chief, Division of Clinical Informatics, Beth Israel Deaconess Medical Center, United States
DCI Network’s EMPATHICA: A Chatbot for Enhancing Medication Communication to Patients
Have an account?